Extremely Preterm Infant Skin Care: A Transformation of Practice Aimed to Prevent Harm

Advances in Neonatal Care

Volumn 16, Issue , 2016, Pages S26-S32

  Johnson, Deanna E ^a   Samra, Haifa A ^a  

^a CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

Author keywords

anetoderma of prematurity; barrier function; harm prevention; medical adhesive related skin injury; neonatal skin care; premature infant skin care

Indexed keywords

EID: 84998533054     PISSN: 15360903     EISSN: 15360911     Source Type: Journal    
DOI: 10.1097/ANC.0000000000000335     Document Type: Article

References (18)

1. Lund C, Kuller J, Lane A, Lott JW, Raines D. Neonatal skin care: The scientific basis for practice. J Obstet Gynecol Neonatal Nurs. 1999; 28: 241-254.
2. Kalia Y, Nonato L, Lund C, Guy R. Development of skin barrier function in preterm infants. J Invest Dermatol. 1998: 111; 320-326.
3. Fluhr JW, Darlenski R, Taieb A, et al. Functional skin adaptation in infancy-almost complete but not fully complete. Exp Dermatol. 2010; 19: 483-492.
4. Fluhr JW, Darlenski R, Lachmann N, et al. Infant epidermal skin physiology: Adaptation after birth. Br J Dermatol. 2012; 166: 483-490.
5. Lund C. Medical adhesives in the NICU. Newborn Infant Nurs Rev. 2014; 14: 160-165.
6. Goujon E, Beer F, Gay S, Sandre D, Gouyon J-B, Vabres P. Anetoderma of prematurity: An iatrogenic consequences of neonatal intensive care. Arch Dermatol. 2010; 5: 565-567.
7. Maffeis L, Pugni L, Pietrasanta C, et al. Iatrogenic anetoderma of prematurity: A case report and review of the literature. Case Rep Dermatol Med. 2014;2014: 781493.
8. Boralevi F, Hubiche T, Leaute-Labreze C, et al. Epicutaneous aeroallergen sensitization in atopic dermatitis infants-determining the role of epidermal barrier impairment. Allergy. 2008; 63: 205-210.
9. Spergel J, Paller A. Atopic dermatitis and the atopic march. J Allery Clin Immunol. 2003; 112: S118-S127.
10. Chang M, Nakrani R. Six children with allergic contact dermatitis to methylisothiazolinone in wet wipes (baby wipes). Pediatrics. 2014; 133 (2): e434-e438.
11. Ponnusamy V, Venkatesh V, Clarke P. Skin antisepsis in the neonate: what should we use Curr Opin Infect Dis. 2014; 27: 244-250.
12. Chapman A, Aucott S, Gilmore M, Advani S, Clarke W, Milstone A. Absorption and tolerability of aqueous chlorhexidine gluconate used for skin antisepsis prior to catheter insertion in preterm neonates. J Perinatol. 2013; 33 (10): 768-771.
13. O'Grady NP, Alexander M, Burns LA, et al. Guidelines for the prevention of intravascular catheter-related infections. Healthcare Infection Control Practices Advisory Committee. http: //www. cdc. gov/hicpac/ pdf/guidelines/bsi-guidelines-2011. pdf. Published 2011. Accessed July 7, 2016.
14. Chapman A, Aucutt S, Milstone A. Safety of chlorhexidine gluconate used for skin antisepsis in the preterm infant. J Pernitol. 2012; 32: 4-9.
15. Aitken J, Williams F. A systematic review of thyroid dysfunction in preterm neonates exposed to topical iodine. Arch Dis Child Fetal Neontal Ed. 2014; 99: F21-F28.
16. Kiechl-Kohlendorfer U, Berger C, Inzinger R. The effect of daily treatment with an olive oil/lanolin emollient on skin integrity in preterm infants: A randomized controlled trial. Pediatr Dermatol. 2008; 25 (2): 174-178.
17. Connor JM, Soll R, Edwards WH. Topical ointment for preventing infection in preterm infants. Cochrane Database Syst Rev. 2009; (3): CD001150.
18. Cleminson J, McGuire W. Topical emollient for preventing infection in the preterm infant. Cochrane Database Syst Rev. 2016; (1): CD001150.